Amphista Therapeutics

About

Amphista Therapeutics operates as a biopharmaceutical company.

Motherwell,North Lanarkshire,United Kingdom
51 - 100
https://www.amphista.com/

Highlights

Details

Last Funding Type: Series B
Industries: Biopharma,Biotechnology
Founded date: Jan 1, 2017
Number Of Employee: 51 - 100
Operating Status: Active

Amphista Therapeutics operates as a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body's natural processes to selectively and efficiently degrade and remove disease causing proteins.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$60.50M

Amphista Therapeutics has raised a total of $60.50M in funding over 2 rounds. Their latest funding was raised on Dec 13, 2022 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 13, 2022	Series B	—	1	Dementia Discovery Fund	—	Detail
Mar 17, 2021	Series B	$53M	6	Forbion Capital Partners Gilde Healthcare	—	Detail
Apr 7, 2020	Series A	$7.50M	4	Advent Life Sciences	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

9

Amphista Therapeutics is funded by 9 investors. Dementia Discovery Fund and Forbion Capital Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
Dementia Discovery Fund	Yes	Series B
Forbion Capital Partners	Yes	Series B
Gilde Healthcare	Yes	Series B
Advent Life Sciences	—	Series B
BioMotiv	—	Series B
Eli Lilly & Company Foundation	—	Series B
Novartis Venture Fund	—	Series B
European Investment Fund	—	Series A
Scottish Investment Bank	—	Series A